Answers are grounded in this paper and cite their sources.
Fifty adult inpatients, of A.S.A. class I, received 0.03 mg./lb. body weight of lorazepam intramuscularly (I.M.), and 0.4 mg. of atropine I.M., 2 hours before induction of anesthesia. Approximately 60 minutes after injection, these patients appeared calm, sedated, arousable (if asleep), and 49 of the 50 had no recollection of leaving their rooms, nor did they recall their experiences in the operating suite or recovery room. An additional 30 adult patients, of A.S.A. classes I and II, received a fixed dose of 5 mg. of lorazepam I.M., without atropine (15 patients) or with atropine (0.4 mg. I.M.) (15 patients) approximately 2 hours before going to the operating room. Cardiac output, tidal and minute volumes, and vital signs were recorded before and 90 minutes after the lorazepam injection. Six patients in the lorazepam-only group and 5 in the atropine group had an increase in cardiac output, 7 in each group had a decrease, and 5 (2 and 3, respectively) showed no change. These changes and those in tidal and minute volumes were not statistically significant by covariance analysis. Lorazepam appears to have ideal qualities for a premedicant: sedation, achieved with minimal cardiopulmonary depression, absence of irritation at the injection site and, uniquely, complete absence of recall of the operating room and recovery room experiences. These properties warrant further investigation into the use of lorazepam as a premedicant of choice before anesthesia and surgical procedures.
No takes yet. Share an insight, caveat, or question.
Knapp et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: